Novo Nordisk Follows Lilly To Lower-Priced Insulin

 
• By David Wallace
  
Insulin
A drop in the price of insulin aspart will result from Novo Nordisk’s authorized generics • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Policy & Regulation